Evidence map›Paper›PMID 33562479›Full record

ReviewMedicina (Kaunas, Lithuania)2021

Made in Germany: A Quality Indicator Not Only in the Automobile Industry But Also When It Comes to Skin Replacement: How an Automobile Textile Research Institute Developed a New Skin Substitute.

Herbert Leopold Haller, Matthias Rapp, Daniel Popp, Sebastian Philipp Nischwitz, Lars Peter Kamolz

Open access · goldAbstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Herbert Leopold HallerUKH Linz der AUVA, HLMedConsult, Zehetlandweg 7, A-4060 Leonding, Austria.ORCID 0000-0002-4996-4199
Matthias RappKlinik für Orthopädie, Unfallchirurgie und Sporttraumatologie, Zentrum für Schwerbrandverletzte, Marienhospital Stuttgart, Böheimstraße 37, 70199 Stuttgart, Germany.
Daniel PoppDivision of Hand, Plastic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, A-8036 Graz, Austria.
Sebastian Philipp NischwitzDivision of Hand, Plastic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, A-8036 Graz, Austria.ORCID 0000-0002-6621-4891
Lars Peter KamolzDivision of Hand, Plastic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, A-8036 Graz, Austria.
Medical University of Graz · ATAllgemeine Unfallversicherungsanstalt · ATMarienhospital Stuttgart · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Successful research and development cooperation between a textile research institute, the German Federal Ministry of Education and Research via the Center for Biomaterials and Organ Substitutes, the University of Tübingen, and the Burn Center of Marienhospital, Stuttgart, Germany, led to the development of a fully synthetic resorbable temporary epidermal skin substitute for the treatment of burns, burn-like syndromes, donor areas, and chronic wounds. This article describes the demands of the product and the steps that were taken to meet these requirements. The material choice was based on the degradation and full resorption of polylactides to lactic acid and its salts. The structure and morphology of the physical, biological, and degradation properties were selected to increase the angiogenetic abilities, fibroblasts, and extracellular matrix generation. Water vapor permeability and plasticity were adapted for clinical use. The available scientific literature was screened for the use of this product. A clinical application demonstrated pain relief paired with a reduced workload, fast wound healing with a low infection rate, and good cosmetic results. A better understanding of the product's degradation process explained the reduction in systemic oxidative stress shown in clinical investigations compared to other dressings, positively affecting wound healing time and reducing the total area requiring skin grafts. Today, the product is in clinical use in 37 countries. This article describes its development, the indications for product growth over time, and the scientific foundation of treatments.

Indexed as

Skin, ArtificialAcademies and InstitutesAutomobilesGermanyHumansQuality Indicators, Health CareTextilesanalgesiaburndonor arealactormoneoxidative stress reductionpolylactidereduced infectionstabilizationwounds

Identifiers

PMID33562479
PMCPMC7914466
OpenAlexW3128397545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.